van Poppelen Daniël, Tromp Annelie N M, de Bie Rob M A, Dijk Joke M
Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
J Pers Med. 2021 Jun 12;11(6):547. doi: 10.3390/jpm11060547.
(1) Background: Deep brain stimulation (DBS) and continuous intrajejunal levodopa infusion (CLI) are efficacious treatments of medication related motor response fluctuations in advanced Parkinson's disease (PD). Literature regarding the use of both advanced treatments within one patient is scarce. (2) Methods: We present a retrospective single center case series and a review of the literature. Patients with PD who were treated with both DBS and CLI in our tertiary referral center between 2005 and 2020 were identified and medical records were assessed. Additionally, literature on patients treated with both therapies was systematically searched for in Medline and Embase. (3) Results: Nineteen patients were included. Medication related motor response fluctuations were a major indication for the second therapy in all but one. Of nine patients initially treated with DBS, five reported improvement with CLI. Seven of ten patients initially treated with CLI experienced benefits from DBS. The systematic literature search resulted in fifteen previous publications comprising 66 patients. Of the 59 patients, for whom the effect of the second treatment was known, 57 improved. (4) Conclusions: PD patients, who have persisting medication related motor response fluctuations, despite DBS or CLI treatment, may benefit from an additional or alternative treatment with either CLI or DBS.
(1) 背景:脑深部电刺激术(DBS)和空肠内持续左旋多巴输注(CLI)是治疗晚期帕金森病(PD)中与药物相关的运动反应波动的有效方法。关于在同一患者中使用这两种先进治疗方法的文献很少。(2) 方法:我们展示了一个回顾性单中心病例系列并进行了文献综述。确定了2005年至2020年间在我们的三级转诊中心接受DBS和CLI治疗的PD患者,并评估了他们的病历。此外,在Medline和Embase中系统搜索了接受两种疗法治疗的患者的文献。(3) 结果:纳入了19名患者。除1名患者外,与药物相关的运动反应波动是所有患者接受第二种治疗的主要指征。在最初接受DBS治疗的9名患者中,5名报告CLI治疗后有所改善。在最初接受CLI治疗的10名患者中,7名从DBS治疗中获益。系统的文献检索得出15篇先前的出版物,共66名患者。在已知第二种治疗效果的59名患者中,57名病情有所改善。(4) 结论:尽管接受了DBS或CLI治疗,但仍存在与药物相关的运动反应波动的PD患者,可能会从额外的或替代的CLI或DBS治疗中获益。